Replimune (REPL) Accumulated Expenses (2018 - 2026)

Replimune (REPL) has 9 years of Accumulated Expenses data on file, last reported at $47.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 3.48% year-over-year to $47.5 million; the trailing twelve-month figure through Mar 2026 stood at $47.5 million (up 3.48% YoY), and the FY2026 full-year result was $47.5 million, up 3.48% from the prior year.
• Accumulated Expenses improved to $47.5 million in Q1 2026, from $40.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $47.5 million in Q1 2026 to a low of $12.2 million in Q2 2022.
• A 5-year average of $30.6 million and a median of $31.4 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses soared 98.58% in 2023 and fell 0.72% in 2024, its largest moves.
• Tracing REPL's Accumulated Expenses over 5 years: stood at $19.2 million in 2022, then surged by 61.22% to $30.9 million in 2023, then increased by 19.02% to $36.8 million in 2024, then gained by 9.81% to $40.4 million in 2025, then increased by 17.72% to $47.5 million in 2026.
• Business Quant data shows REPL's Accumulated Expenses at $47.5 million in Q1 2026, $40.4 million in Q4 2025, and $42.4 million in Q3 2025.